Clinical Trials in San Antonio

Showing 5021-5040 of 11,125 trials

A Study to Assess Safety of Cedirogant and How Cedirogant Moves Through the Body in Adult Participants With Mild, Moderate and Severe Hepatic Impairment

NCT05376839

The objective of this study is to evaluate the pharmacokinetics and safety of cedirogant following oral administration of multiple doses in adult participants with hepatic impairment and normal hepatic function.

Hepatic Impairment

AbbVie6 participantsStarted Jul 2022

Miami, Florida, United States • Orlando, Florida, United States • San Antonio, Texas, United States

COMPLETEDPhase 3< 1 mile

Phase 3 Study of Hydrocodone Bitartrate Controlled-release Capsules in Subjects With Chronic Low Back Pain

NCT01081912

The purpose of the study is to evaluate the safety and efficacy of Hydrocodone Bitartrate controlled-release capsules in subjects with chronic low back pain.

Back Pain Lower Back Chronic

Zogenix, Inc.510 participantsStarted Mar 2010

Phoenix, Arizona, United States • Jonesboro, Arkansas, United States • Anaheim, California, United States +48 more locations

A Study to Assess Safety of Cedirogant and How Cedirogant Moves Through the Body in Adult Participants With Mild, Moderate and Severe Hepatic Impairment

Phase 3 Study of Hydrocodone Bitartrate Controlled-release Capsules in Subjects With Chronic Low Back Pain

Find Trials by Condition in San Antonio

Niraparib in Combination With Pembrolizumab in Patients With Triple-negative Breast Cancer or Ovarian Cancer

Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy

Optimizing Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502)

Study to Assess Darbepoetin Alfa Dosing for the Correction of Anemia in Pediatric Patients With Chronic Kidney Disease

A Study to Test Whether Different Doses of BI 456906 Are Effective in Treating Adults With Type 2 Diabetes.

Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis

Reduced Intensity Conditioning for Hemophagocytic Syndromes or Selected Primary Immune Deficiencies (BMT CTN 1204)

A Study to Test if TV-46000 is Safe for Maintenance Treatment of Schizophrenia

Addition of ISIS 14803 to Therapy With Peginterferon and Ribavirin for Chronic Hepatitis C (HCV) Patients Not Responding Adequately to the Two Drugs

Engaging Seronegative Youth to Optimize HIV Prevention Continuum

A Study of Use of Ella®, an Emergency Contraceptive, Under Simulated OTC Conditions

Safety Study of Nivolumab to Treat Advanced or Metastatic Non-small Cell Lung Cancer

Investigation of Sulindac (HLX-0201) and Gaboxadol (HLX-0206) in Male Fragile X Syndrome Patients Aged 13-40

Safety And Tolerability Of Subcutaneous MANP In Difficult To Control/Resistant Hypertensive Subjects

A Prospective, Epidemiological Study to Assess the Disease Burden of Respiratory Syncytial Virus Associated, Suspected Lower Respiratory Tract Infections in Newborns, From 0 to 2 Years of Age and Risk of Development of Wheeze and Asthma From 0 to 6 Years of Age

Efficacy and Tolerability Study of Two Dose Regimens of CTP-543 in Adults With Alopecia Areata

A Clinical Trial of PRAX-114 in Participants With Essential Tremor

Low-Level Laser Therapy Treatment of Lung Inflammation in Post-COVID-19 Recovery